Prescription drug · ANDA
Lidocaine Hydrochloride NDC 76329-3011
Lidocaine hydrochloride 20 mg/mL · Jelly · Topical · International Medication Systems, Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 76329-3011-5 | 76329301105 | 25 VIAL, SINGLE-USE in 1 BOX (76329-3011-5) / 5 mL in 1 VIAL, SINGLE-USEMarketed from Aug 7, 1979 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lidocaine Hydrochloride
- Generic name (nonproprietary)
- lidocaine hydrochloride
- Active ingredients
- Lidocaine hydrochloride — 20 mg/mL
- Dosage form
- Jelly
- Route
- Topical
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 086283
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 76329-3011_483019ba-e338-42f2-82da-2401e40e417cSPL ID 483019ba-e338-42f2-82da-2401e40e417cSPL set ID 0cbc37d3-c2d6-4747-9834-7c23b38fcc20RxCUI 1011852UNII V13007Z41A
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N476329301105followed by a unit qualifier and the quantityPackage 76329-3011-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE: Lidocaine Hydrochloride Jelly USP, 2% is indicated for prevention and control of pain in procedures involving the male and female urethra for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation (oral and nasal).
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 086283
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | JellyTopical | International Medication Systems, Limited | 76329-3015 |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | JellyTopical | International Medication Systems, Limited | 76329-3012 |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | JellyTopical | International Medication Systems, Limited | 76329-3013 |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | JellyTopical | HF Acquisition Co LLC, DBA HealthFirst | 51662-1551 |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | JellyTopical | HF Acquisition Co LLC, DBA HealthFirst | 51662-1552 |
| Lidocaine Hci | Lidocaine hydrochloride 20 mg/mL | JellyTopical | HF Acquisition Co LLC, DBA HealthFirst | 51662-1389 |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | JellyTopical | Henry Schein, Inc. | 0404-9898 |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | JellyTopical | Henry Schein, Inc. | 0404-9899 |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | JellyTopical | Henry Schein, Inc. | 0404-9900 |